Approval · Notice of Compliance 8825 · 2007
SINGULAIR: Notice of Compliance 8825
Issued June 8, 2007
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 8825
- Date
- June 8, 2007
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Revisions to the drug interactions section and other revisions to the product monograph
- Therapeutic class
- Leukotriene receptor antagonist
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| SINGULAIR | Not yet assigned | — |
Medicinal ingredients
- MONTELUKAST SODIUM 10 MG per TAB
- MONTELUKAST SODIUM 5 MG per TAB
- MONTELUKAST SODIUM 4 MG per TAB
- MONTELUKAST SODIUM 4 MG per PCK